Chime Biologics GMP-2 Opening and KuBio 10th Anniversary

关于 chi9iua

This author has not written his bio yet.
But we are proud to say that chi9iua contributed 74 entries already.

日志 chi9iua

(English) Chime Biologics GMP-2 Opening and KuBio 10th Anniversary

April 24, 2026/在： Event, NewsRoom, Uncategorized/通过： chi9iua

在生物药制造中驾驭人工智能的力量

April 22, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

从武汉出发，链接韩国生物医药创新-鼎康生物赋能韩国生物药产业新格局

April 17, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

生物类似药制胜之道：速度、规模与新竞争策略

April 3, 2026/在： Corporate News, Story, Uncategorized/通过： chi9iua

(English) BioEquity Europe 2026

April 1, 2026/在： Event, NewsRoom, Uncategorized/通过： chi9iua

鼎康生物祝贺和其瑞医药(Hope Medicine Inc.)子宫内膜异位症III期临床试验中国首例患者成功给药

March 27, 2026/在： Corporate News, News, Uncategorized/通过： chi9iua

生物类似药：在全球生物药产业重塑中寻找新的普惠路径

March 25, 2026/在： Corporate News, NewsRoom, Story/通过： chi9iua

(English) Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today

March 2, 2026/在： News, NewsRoom/通过： chi9iua

对不起，此内容只适用于English。 For the sake of viewer convenience, […]

(English) Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier

January 26, 2026/在： News, NewsRoom/通过： chi9iua

对不起，此内容只适用于English。 For the sake of viewer convenience, […]

鼎康生物宣布与北京力邦生物在全球贝林妥欧单抗生物类似药项目上达成战略合作

December 10, 2025/在： Corporate News, News/通过： chi9iua